Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedAdds sponsor/author identifiers (Huilan Zhang; Tongji Hospital) and related metadata fields (Last verified, Last known status was). It also introduces new help links (How to Read a Study Record, Common Questions, How to Join a Study) and a UI revision tag (Revision: v3.6.0), reflecting an update to page metadata and navigation.SummaryDifference2%

- Check8 days agoChange DetectedThe page revision was updated to v3.5.5, signaling a new version of the page. This typically represents minor documentation or metadata updates rather than substantive changes to study details.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's metadata and formatting.SummaryDifference0.1%

- Check51 days agoChange DetectedThis updates the ClinicalTrials.gov page revision/version indicator (v3.5.3 instead of v3.5.0), indicating a site release change rather than a modification to the study details.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.1%

- Check101 days agoChange DetectedSite revision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.